238 related articles for article (PubMed ID: 15198439)
1. Treatment optimization in multiple sclerosis.
Freedman MS; Patry DG; Grand'Maison F; Myles ML; Paty DW; Selchen DH;
Can J Neurol Sci; 2004 May; 31(2):157-68. PubMed ID: 15198439
[TBL] [Abstract][Full Text] [Related]
2. Treatment optimization in MS: Canadian MS Working Group updated recommendations.
Freedman MS; Selchen D; Arnold DL; Prat A; Banwell B; Yeung M; Morgenthau D; Lapierre Y;
Can J Neurol Sci; 2013 May; 40(3):307-23. PubMed ID: 23603165
[TBL] [Abstract][Full Text] [Related]
3. Treatment optimisation in multiple sclerosis.
Zaffaroni M
Neurol Sci; 2005 Dec; 26 Suppl 4():S187-92. PubMed ID: 16388356
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging treatment of multiple sclerosis.
Hart FM; Bainbridge J
Am J Manag Care; 2016 Jun; 22(6 Suppl):s159-70. PubMed ID: 27356025
[TBL] [Abstract][Full Text] [Related]
5. Brain health: time matters in multiple sclerosis.
Giovannoni G; Butzkueven H; Dhib-Jalbut S; Hobart J; Kobelt G; Pepper G; Sormani MP; Thalheim C; Traboulsee A; Vollmer T
Mult Scler Relat Disord; 2016 Sep; 9 Suppl 1():S5-S48. PubMed ID: 27640924
[TBL] [Abstract][Full Text] [Related]
6. Impact of diagnosis and early treatment on the course of multiple sclerosis.
Noyes K; Weinstock-Guttman B
Am J Manag Care; 2013 Nov; 19(17 Suppl):s321-31. PubMed ID: 24494633
[TBL] [Abstract][Full Text] [Related]
7. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
Miller DH; Grossman RI; Reingold SC; McFarland HF
Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
[TBL] [Abstract][Full Text] [Related]
8. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations.
Freedman MS; Devonshire V; Duquette P; Giacomini PS; Giuliani F; Levin MC; Montalban X; Morrow SA; Oh J; Rotstein D; Yeh EA;
Can J Neurol Sci; 2020 Jul; 47(4):437-455. PubMed ID: 32654681
[TBL] [Abstract][Full Text] [Related]
9. Multiple Sclerosis.
Yamout BI; Alroughani R
Semin Neurol; 2018 Apr; 38(2):212-225. PubMed ID: 29791948
[TBL] [Abstract][Full Text] [Related]
10. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Yes].
Brochet B
Rev Neurol (Paris); 2013 Nov; 169(11):858-63. PubMed ID: 24094530
[TBL] [Abstract][Full Text] [Related]
11. Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS.
Corboy JR; Weinshenker BG; Wingerchuk DM
Neurology; 2018 Jun; 90(24):1106-1112. PubMed ID: 29685920
[TBL] [Abstract][Full Text] [Related]
12. Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.
Lebrun C; Vukusic S; ;
Rev Neurol (Paris); 2019 Jun; 175(6):341-357. PubMed ID: 31036391
[TBL] [Abstract][Full Text] [Related]
13. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.
Gold R; Oreja-Guevara C
Expert Rev Neurother; 2013 Dec; 13(12 Suppl):55-9. PubMed ID: 24289845
[TBL] [Abstract][Full Text] [Related]
14. An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple Sclerosis.
Vaughn C; Bushra A; Kolb C; Weinstock-Guttman B
CNS Drugs; 2018 Feb; 32(2):161-178. PubMed ID: 29508244
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E;
J Clin Neurosci; 2014 Nov; 21(11):1847-56. PubMed ID: 24986155
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force.
Miller DH
Mult Scler; 1996 Jul; 1(6):335-8. PubMed ID: 9345412
[TBL] [Abstract][Full Text] [Related]
17. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No].
Edan G
Rev Neurol (Paris); 2013 Nov; 169(11):864-8. PubMed ID: 24125462
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
19. Is the Choosing Wisely
Trumbic B; Zéphir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; de Sèze J
Rev Neurol (Paris); 2018; 174(1-2):28-35. PubMed ID: 29128151
[TBL] [Abstract][Full Text] [Related]
20. Survey of diagnostic and treatment practices for multiple sclerosis in Europe.
Fernández O; Delvecchio M; Edan G; Fredrikson S; Gionvannoni G; Hartung HP; Havrdova E; Kappos L; Pozzilli C; Soerensen PS; Tackenberg B; Vermersch P; Comi G
Eur J Neurol; 2017 Mar; 24(3):516-522. PubMed ID: 28139062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
